Redox Imbalances in Ageing and Metabolic Alterations: Implications in Cancer and Cardiac Diseases. An Overview from the Working Group of Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology (SIC)

Metabolic syndrome (MetS) is a well established risk factor for cardiovascular (CV) diseases. In addition, several studies indicate that MetS correlates with the increased risk of cancer in adults. The mechanisms linking MetS and cancer are not fully understood. Several risk factors involved in MetS...

Full description

Bibliographic Details
Main Authors: Valentina Mercurio, Alessandra Cuomo, Christian Cadeddu Dessalvi, Martino Deidda, Daniela Di Lisi, Giuseppina Novo, Roberta Manganaro, Concetta Zito, Ciro Santoro, Pietro Ameri, Paolo Spallarossa, Eleonora Arboscello, Carlo Gabriele Tocchetti, Claudia Penna
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/9/7/641
_version_ 1797561798822461440
author Valentina Mercurio
Alessandra Cuomo
Christian Cadeddu Dessalvi
Martino Deidda
Daniela Di Lisi
Giuseppina Novo
Roberta Manganaro
Concetta Zito
Ciro Santoro
Pietro Ameri
Paolo Spallarossa
Eleonora Arboscello
Carlo Gabriele Tocchetti
Claudia Penna
author_facet Valentina Mercurio
Alessandra Cuomo
Christian Cadeddu Dessalvi
Martino Deidda
Daniela Di Lisi
Giuseppina Novo
Roberta Manganaro
Concetta Zito
Ciro Santoro
Pietro Ameri
Paolo Spallarossa
Eleonora Arboscello
Carlo Gabriele Tocchetti
Claudia Penna
author_sort Valentina Mercurio
collection DOAJ
description Metabolic syndrome (MetS) is a well established risk factor for cardiovascular (CV) diseases. In addition, several studies indicate that MetS correlates with the increased risk of cancer in adults. The mechanisms linking MetS and cancer are not fully understood. Several risk factors involved in MetS are also cancer risk factors, such as the consumption of high calorie-food or high fat intake, low fibre intake, and sedentary lifestyle. Other common aspects of both cancer and MetS are oxidative stress and inflammation. In addition, some anticancer treatments can induce cardiotoxicity, including, for instance, left ventricular (LV) dysfunction and heart failure (HF), endothelial dysfunction and hypertension. In this review, we analyse several aspects of MetS, cancer and cardiotoxicity from anticancer drugs. In particular, we focus on oxidative stress in ageing, cancer and CV diseases, and we analyse the connections among CV risk factors, cancer and cardiotoxicity from anticancer drugs.
first_indexed 2024-03-10T18:19:45Z
format Article
id doaj.art-504debdf79ed4918a2ef91d29cac4f77
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-10T18:19:45Z
publishDate 2020-07-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-504debdf79ed4918a2ef91d29cac4f772023-11-20T07:26:21ZengMDPI AGAntioxidants2076-39212020-07-019764110.3390/antiox9070641Redox Imbalances in Ageing and Metabolic Alterations: Implications in Cancer and Cardiac Diseases. An Overview from the Working Group of Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology (SIC)Valentina Mercurio0Alessandra Cuomo1Christian Cadeddu Dessalvi2Martino Deidda3Daniela Di Lisi4Giuseppina Novo5Roberta Manganaro6Concetta Zito7Ciro Santoro8Pietro Ameri9Paolo Spallarossa10Eleonora Arboscello11Carlo Gabriele Tocchetti12Claudia Penna13Department of Translational Medical Sciences, Federico II University, 80131 Naples, ItalyDepartment of Translational Medical Sciences, Federico II University, 80131 Naples, ItalyDepartment of Medical Sciences and Public Health, University of Cagliari, 09042 Cagliari, ItalyDepartment of Medical Sciences and Public Health, University of Cagliari, 09042 Cagliari, ItalyCardiology Unit AUOP Policlinico, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, ItalyCardiology Unit AUOP Policlinico, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, 90127 Palermo, ItalyCardiology with Coronary Intensive Care Unit, Department of Clinical and Experimental Medicine, University Hospital Policlinico “G. Martino”, University of Messina, 98124 Messina, ItalyCardiology with Coronary Intensive Care Unit, Department of Clinical and Experimental Medicine, University Hospital Policlinico “G. Martino”, University of Messina, 98124 Messina, ItalyDepartment of Advanced Biomedical Sciences, Federico II University, 80131 Naples, ItalyCardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy—IRCCS Italian Cardiovascular Network & Department of Internal Medicine, University of Genova, 16121 Genova, ItalyCardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy—IRCCS Italian Cardiovascular Network & Department of Internal Medicine, University of Genova, 16121 Genova, ItalyCardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino, Genova, Italy—IRCCS Italian Cardiovascular Network & Department of Internal Medicine, University of Genova, 16121 Genova, ItalyDepartment of Translational Medical Sciences, Federico II University, 80131 Naples, ItalyDepartment of Clinical and Biological Sciences, University of Turin, 10043 Torino, ItalyMetabolic syndrome (MetS) is a well established risk factor for cardiovascular (CV) diseases. In addition, several studies indicate that MetS correlates with the increased risk of cancer in adults. The mechanisms linking MetS and cancer are not fully understood. Several risk factors involved in MetS are also cancer risk factors, such as the consumption of high calorie-food or high fat intake, low fibre intake, and sedentary lifestyle. Other common aspects of both cancer and MetS are oxidative stress and inflammation. In addition, some anticancer treatments can induce cardiotoxicity, including, for instance, left ventricular (LV) dysfunction and heart failure (HF), endothelial dysfunction and hypertension. In this review, we analyse several aspects of MetS, cancer and cardiotoxicity from anticancer drugs. In particular, we focus on oxidative stress in ageing, cancer and CV diseases, and we analyse the connections among CV risk factors, cancer and cardiotoxicity from anticancer drugs.https://www.mdpi.com/2076-3921/9/7/641cancercardiovascular toxicity from anticancer drugscardiovascular diseaseageingmetabolic syndrome
spellingShingle Valentina Mercurio
Alessandra Cuomo
Christian Cadeddu Dessalvi
Martino Deidda
Daniela Di Lisi
Giuseppina Novo
Roberta Manganaro
Concetta Zito
Ciro Santoro
Pietro Ameri
Paolo Spallarossa
Eleonora Arboscello
Carlo Gabriele Tocchetti
Claudia Penna
Redox Imbalances in Ageing and Metabolic Alterations: Implications in Cancer and Cardiac Diseases. An Overview from the Working Group of Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology (SIC)
Antioxidants
cancer
cardiovascular toxicity from anticancer drugs
cardiovascular disease
ageing
metabolic syndrome
title Redox Imbalances in Ageing and Metabolic Alterations: Implications in Cancer and Cardiac Diseases. An Overview from the Working Group of Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology (SIC)
title_full Redox Imbalances in Ageing and Metabolic Alterations: Implications in Cancer and Cardiac Diseases. An Overview from the Working Group of Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology (SIC)
title_fullStr Redox Imbalances in Ageing and Metabolic Alterations: Implications in Cancer and Cardiac Diseases. An Overview from the Working Group of Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology (SIC)
title_full_unstemmed Redox Imbalances in Ageing and Metabolic Alterations: Implications in Cancer and Cardiac Diseases. An Overview from the Working Group of Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology (SIC)
title_short Redox Imbalances in Ageing and Metabolic Alterations: Implications in Cancer and Cardiac Diseases. An Overview from the Working Group of Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology (SIC)
title_sort redox imbalances in ageing and metabolic alterations implications in cancer and cardiac diseases an overview from the working group of cardiotoxicity and cardioprotection of the italian society of cardiology sic
topic cancer
cardiovascular toxicity from anticancer drugs
cardiovascular disease
ageing
metabolic syndrome
url https://www.mdpi.com/2076-3921/9/7/641
work_keys_str_mv AT valentinamercurio redoximbalancesinageingandmetabolicalterationsimplicationsincancerandcardiacdiseasesanoverviewfromtheworkinggroupofcardiotoxicityandcardioprotectionoftheitaliansocietyofcardiologysic
AT alessandracuomo redoximbalancesinageingandmetabolicalterationsimplicationsincancerandcardiacdiseasesanoverviewfromtheworkinggroupofcardiotoxicityandcardioprotectionoftheitaliansocietyofcardiologysic
AT christiancadeddudessalvi redoximbalancesinageingandmetabolicalterationsimplicationsincancerandcardiacdiseasesanoverviewfromtheworkinggroupofcardiotoxicityandcardioprotectionoftheitaliansocietyofcardiologysic
AT martinodeidda redoximbalancesinageingandmetabolicalterationsimplicationsincancerandcardiacdiseasesanoverviewfromtheworkinggroupofcardiotoxicityandcardioprotectionoftheitaliansocietyofcardiologysic
AT danieladilisi redoximbalancesinageingandmetabolicalterationsimplicationsincancerandcardiacdiseasesanoverviewfromtheworkinggroupofcardiotoxicityandcardioprotectionoftheitaliansocietyofcardiologysic
AT giuseppinanovo redoximbalancesinageingandmetabolicalterationsimplicationsincancerandcardiacdiseasesanoverviewfromtheworkinggroupofcardiotoxicityandcardioprotectionoftheitaliansocietyofcardiologysic
AT robertamanganaro redoximbalancesinageingandmetabolicalterationsimplicationsincancerandcardiacdiseasesanoverviewfromtheworkinggroupofcardiotoxicityandcardioprotectionoftheitaliansocietyofcardiologysic
AT concettazito redoximbalancesinageingandmetabolicalterationsimplicationsincancerandcardiacdiseasesanoverviewfromtheworkinggroupofcardiotoxicityandcardioprotectionoftheitaliansocietyofcardiologysic
AT cirosantoro redoximbalancesinageingandmetabolicalterationsimplicationsincancerandcardiacdiseasesanoverviewfromtheworkinggroupofcardiotoxicityandcardioprotectionoftheitaliansocietyofcardiologysic
AT pietroameri redoximbalancesinageingandmetabolicalterationsimplicationsincancerandcardiacdiseasesanoverviewfromtheworkinggroupofcardiotoxicityandcardioprotectionoftheitaliansocietyofcardiologysic
AT paolospallarossa redoximbalancesinageingandmetabolicalterationsimplicationsincancerandcardiacdiseasesanoverviewfromtheworkinggroupofcardiotoxicityandcardioprotectionoftheitaliansocietyofcardiologysic
AT eleonoraarboscello redoximbalancesinageingandmetabolicalterationsimplicationsincancerandcardiacdiseasesanoverviewfromtheworkinggroupofcardiotoxicityandcardioprotectionoftheitaliansocietyofcardiologysic
AT carlogabrieletocchetti redoximbalancesinageingandmetabolicalterationsimplicationsincancerandcardiacdiseasesanoverviewfromtheworkinggroupofcardiotoxicityandcardioprotectionoftheitaliansocietyofcardiologysic
AT claudiapenna redoximbalancesinageingandmetabolicalterationsimplicationsincancerandcardiacdiseasesanoverviewfromtheworkinggroupofcardiotoxicityandcardioprotectionoftheitaliansocietyofcardiologysic